D Thorp

Peripheral Blood Progenitor Cell Transplantation: Clinical, Practical, and Economic Considerations

Automated Enumeration of CD34 ⁺ Cells in Peripheral Blood and Bone Marrow

Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis

Defining a Therapeutic Dose of Peripheral Blood Stem Cells

The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

Use of plasma exchange in patients with heparin‐induced thrombocytopenia: A report of two cases and a review of the literature

Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment

Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice —Part 2

Ex vivo manipulation of hematopoietic stem and progenitor cells

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings

Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential

Cytokines and hematopoietic stem cell mobilization

A Comparative Review of Colony-Stimulating Factors

Heparin-Induced Thrombocytopenia

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients

Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry

Proliferating dendritic cell progenitors in human blood.

Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

The Absolute Number of Peripheral Blood CD34+ Cells Predicts a Timing for Apheresis and Progenitor Cell Yield in Patients with Hematologic Malignancies and Solid Tumors

Gene correction in hematopoietic progenitor cells by homologous recombination

Peripheral Blood Stem Cell Transplantations: Past, present and future

Enrichment of human hematopoietic stem cell activity in the CD34+Thy- 1+Lin- subpopulation from mobilized peripheral blood

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

Heparin-induced thrombocytopenia

Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation

Evaluation of Hematological Reconstitution Potential of Autologous Peripheral Blood Progenitor Cells Cryopreserved by a Simple Controlled-Rate Freezing Method

Polysialic acid governs T-cell development by regulating progenitor access to the thymus

Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy

Functional Differences between Subpopulations of Mobilized Peripheral Blood‐Derived CD34⁺Cells Expressing Different Levels of HLA‐DR, CD33, CD38 and c‐kit Antigens

Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood.

The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia.

Successful peripheral blood stem‐cell autograft with a near‐critical dose of myeloid progenitor cells in acute non‐lymphoblastic leukaemia in relapse

Autologous blood stem cell transplantation.

Autotransplantation using peripheral blood stem cells mobilized by cyclophosphamide.

Plasma exchange and heparin-induced thrombocytopenia.

Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.

A comparison between 4 GM/M2 and 7 GM/M2 cyclophosphamide for peripheral blood stem cell mobilization

An unusual pattern of hemopoietic reconstitution in patients with acute myeloid leukemia transplanted with autologous recovery phase peripheral blood.